Physician profile

Matthew M Ralsten

Obstetrics & Gynecology · Fayetteville, GA

NPI 1184654394

$64,435.20

in general payments reported to CMS, 2019-2025

44 companies · $3,221 in 2025

The $3,221 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$17,000.00
Travel and Lodging$5,916.06
Food and Beverage$3,408.89
Education$1,500.00
Consulting Fee$750.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Applied Medical Resources Corporation $51,875.91 2019-2025 Gelpoint V-Path
Intuitive Surgical, INC. $3,704.29 2024-2025
Minerva Surgical, INC $2,597.78 2019-2024
Momentis Surgical INC. $1,290.97 2021-2023 Anovo Surgical System
Abbvie INC. $717.32 2019-2025
Mayne Pharma Commercial LLC $659.60 2021-2025
Coopersurgical, INC. $351.27 2019-2025 Endosee, Paragard T 380a, Paragard T 380a
Astellas Pharma US INC $335.98 2019-2024 Veozah, Myrbetriq
Hologic Sales and Service, LLC $284.21 2019-2025 Aptima, Thinprep 2000 Processor, Acessa Provu System
Mimedx Group, INC. $243.17 2024-2025
Biogen, INC. $204.24 2024-2025 Zurzuvae
Daiichi Sankyo INC. $185.34 2019-2022
Therapeuticsmd, INC. $182.18 2019-2022
Sumitomo Pharma America, INC. $146.16 2024-2025 Myfembree, Gemtesa
Aspira Women'S Health INC $130.69 2022-2024 Ova1
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Mylan Pharmaceuticals INC. $125.00 2021-2022
Scynexis, INC. $122.56 2022
Evofem Biosciences, INC. $111.03 2021-2025 Phexxi, Solosec, Phexx
Gynesonics, INC. $108.68 2021
Millicent US INC $107.55 2019-2025 Intrarosa, Femlyv
Exeltis, USA INC. $97.82 2021-2024 Slynd
Pfizer INC. $85.89 2023-2024
Roche Diagnostics Corporation $77.28 2019-2021
Bayer Healthcare Pharmaceuticals INC. $76.80 2023-2025
Agile Therapeutics, INC. $72.58 2021-2023 Twirla
Organon LLC $65.31 2024
Allergan, INC. $50.11 2019-2021
Vertical Pharmaceuticals, LLC $49.17 2019
Boston Scientific Corporation $49.00 2020-2022
Meditrina $36.41 2024-2025
Acessa Health INC. $34.95 2020-2021
Baxter Healthcare $33.59 2024-2025 Perclot, Floseal
Avion Pharmaceuticals $25.97 2019-2021
Bausch Health US, LLC $24.51 2021
Amag Pharmaceuticals, INC. $23.11 2019
Shield Therapeutics INC $22.57 2022
Optumhealth Care Solutions, LLC $19.99 2024 Eitan Medical, Vivify Health Care Team Portal 001
Caldera Medical, INC $18.78 2022
Duchesnay USA Incorporated $17.47 2019
Ethicon US, LLC $16.29 2021
Lsi Solutions INC $15.52 2022
Glaxosmithkline, LLC. $14.47 2019
Lupin INC. $11.87 2019
Medtronic, INC. $11.81 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Matthew M Ralsten

$64,435.20

in general payments reported 2019-2025

Years
2019-2025
Top company
Applied Medical Resources Corporation
Context
The $3,221 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/53001/matthew-m-ralsten

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.